Biodexa Pharmaceuticals shares are trading higher after the company announced it entered into agreements to acquire an exclusive worldwide license to tolimidone.

MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD -2.40%

MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD

BDRX

4.07

-2.40%

Biodexa Pharmaceuticals shares are trading higher after the company announced it entered into agreements to acquire an exclusive worldwide license to tolimidone.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via